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THE LIST OF ABBREVIATIONS 
 
ActIIBR : Activin IIB Receptor 
AKT (PKB) : Protein Kinase B 
Alk: Activin receptor-like kinase  
AMPK: AMP-activated protein kinase 
Ang II: Angiotensin II 
ATP: Adenosine tri-phosphate 
Bnip3: BCL2 Interacting Protein 3 
CM : C26 cell conditioned medium 
DRR: Distal Regulatory Region 
EBS: Ets-binding site 
Edl : Extensor digitorum longus muscle 
ElF4E: Eukaryotic translation initiation factor 4E 
ElF4EBP1: Eukaryotic translation initiation factor 4E-binding 
protein 1 
ERK: Extracellular signal-regulated kinases  
FGF: Fibroblast Growth Factor 
FoxO: Forkhead box O 
Fst: Follistatin 
GSk3: Glycogen Synthase kinase 3 
HGF: Hepatocyte growth factor 
HSA: Human Skeletal Actin 
IEG: Immediate Early Genes 
IFN: Interferon 
IGF-1: Insulin Growth Factor 1 
IkB: Inhibitor of kappa B 
IL: Interleukin 
JAK: janus kinase 
JNK: c-Jun N-terminal kinases 
lc3: microtubule-associated protein1 light chain 3 
LIMK: LIM domain kinase 
LLC: Lewis Lung Carcinoma 
MAFbx/atrogin-1: Muscle Atrophy F-box 
MCK: Muscle Creatine kinase 
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MEF2: Myocyte Enhancer Factor-2 
MEK: Mitogen-activated protein kinase/extracellular signal-
regulated kinase 
MRFs: Myogenic regulatory factors 
MRTFs: Myocardin Related Transcription Factors 
mTOR: mammalian target of rapamycin 
MuRF1: Muscle RING finger 1  
Myf5: Myogenic factor 5 
MyoD: Myogenic Differentiation 
NCAM (CD56): Neural Cell Adhesion Molecule 
NFkB: Nuclear Factor-kappa B 
NLS: Nuclear Localization Signal 
Pax : Paired box protein  
Peg3: Paternally-expressed gene 3 protein  
Pl3K: Phosphoinositide 3-kinase 
ROCK: Rho associated protein kinase 
ROS: Reactive Oxygen Species 
SC: Satellite cells 
SRE: Serum Response Element 
SRF: Serum Response Factor 
STARS: Striated muscle activator of Rho signaling 
STAT: Signal Transducers and Activators of Transcription 
TCF: Ternary complex factor 
TGF-: Tumor Growth Factor  
TNF: Tumor Necrosis Factor  
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THE THESIS EXPLAINED  
Cachexia is characterised by an increased level of pro-inflammatory 
cytokines and other humoral factors, which promote autophagy 
and proteolysis, leading to muscle fiber atrophy. Satellite cells (SC) 
myogenic potential is also hampered and contributes to muscle 
wasting. Clinical studies showed that exercise training improves 
quality of life and survival of cancer patients. In agreement, we 
proved that wheel running maintains body weight of C26 tumor 
bearing mice, due to the rescue of muscle fiber size.  However the 
molecular pathway implicated in response to exercise by the 
skeletal muscle are unknown. Exercise could act thought on muscle 
homeostasis by affecting the levels of circulating factors or by a 
mechanotransduction response of muscle cells. The latter may 
involve Serum Response Factor (SRF) response, which is known to 
be induced by mechanical cues transduced by the actin network. 
To dissociate these pathways, we used an in vitro model, consisting 
of mixed cultures of C2C12 myotubes and myoblasts, treated with 
C26 tumor cells conditioned medium (CM) containing pro-
inflammatory cytokines secreted by C26. Our results showed that 
CM had a negative effect on muscle cells. To study the interaction 
between humoral and mechanical cues, mixed cultures were 
incubated in absence or presence of CM and in absence or 
presence of cyclic stretch. We observed that the effects of CM are 
counteracted by cyclic stretch, suggesting that mechanical effect is 
sufficient to activate a mechanotransduction pathway with pro-
myogenic effects; we had several evidences on SRF involvement in 
this response, associated to an increase of pro-myogenic factors in 
the culture medium potentially able to recruit satellite cells. We 
suggest that the positive effects of exercise on cancer patient and 
murine muscle may be due to a mechanical response of muscle 
fibers to induce myogenic differentiation of satellite cells via 
humoral factors secreted by myofibers. This study could be the 
basis for developing training protocols to counteract cachexia in 
cancer patients. 
 
PhD in Morphogenesis and Tissue Engineering 
                       PhD in Physiology, physiopathology and therapeutics 
 
 9 
INTRODUCTION 
 
1. Muscle mass homeostasis in the adult 
 
The skeletal muscle represents circa 40% of the total body weight. 
In addition to function in locomotion, posture and body 
temperature regulation, skeletal muscle plays an important role in 
the regulation of metabolism.  
 
 
 1.1 Skeletal muscle regeneration  
During embryogenesis and foetal development, progenitor cells 
are involved in myofiber formation: a first wave of cellular fusion 
forms embryonic muscle fibers, while a second wave of fusion 
forms larger and more definitive muscle fibers, the fetal 
musculature, in response to morphogenic factors such as TGF-, 
HGF, etc. Muscle growth is ensured by an increase of fiber 
cytoplasmic volume due to an accumulation of contractile proteins 
and by fusion of satellite cells with fibers.  
 
Satellite cells (SC) are quiescent cells and represent only 2 to 7% of 
the cells associated to muscle fiber. They are characterized by the 
expression of the transcription factors Pax7 and Pax3, as well as 
the myogenic regulator factor Myf5,   adhesion proteins such as 
NCAM (CD56),  M-cadherin, integrin 7 and ; in addition, SC 
express transmembrane proteins syndecan 3 and 4 and also 
nuclear membrane protein like laminin A/C, emirin. SC derive from 
the pax3- and 7- expressing dermomyotome cells. The latter is 
involved in bulk muscle formation dependent on myogenic 
regulator factor expression (MRF).  However, a subpopulation skips 
differentiation and, following a proliferative phase, resides in a 
quiescent state underneath the muscle basal lamina and around 
muscle fibers (hence the name of satellite cells). In adult life SC 
Alexandra BACCAM 
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play a major role in muscle regeneration, as shown by the total 
lack of regeneration following SC ablation (Lepper et al., 2011, 
Murphy et al., 2011),  
SC fate is deeply affected by their microenvironment (the niche): 
cell-dependent, paracrine and mechanical cues all can drive their 
activation or maintain their quiescent state. Paracrine signals of 
muscle fiber origin include follistatin, myostatin and Wnt (Guerci et 
al., 2012, Le Grand et al., 2009, Tran et al., 2012). 
Following muscle fiber injury, satellite cells are stimulated by 
Insulin Growth Factors (IGF), Fibroblast Growth Factor (FGF) and 
other factors of muscle fiber origin. Upon activation, satellite cells 
express MyoD in addition to pax7 and Myf5 and undergo 
symmetric and/or asymmetric division (as summerized in Figure 1) 
becoming myoblasts and, then, myocytes.  They fuse with damage 
muscle and express Mrf4 and myosin heavy chain (Figure 1). SC 
proliferative and regenerative capacity is impressive in mice 5-7. 
SC associated to the Edl muscle give rise to almost 300 nuclei in 
culture in a biologically relevant time frame (Zammit et al., 2002); 
in vivo 50 cycles of extensive injury are not enough to deplete the 
muscle of SC and hamper regeneration (Sadeh et al., 1985). 
 
  
1.2 Muscle masse regulation  
The great plasticity of skeletal muscle allows the organism to adapt 
to a changing demand during adult life: a decrease or a stop of 
mechanical stimulation, fasting or increased loading induce muscle 
fiber atrophy and hypertrophy. Both phenomena are primarily due 
to metabolic events within the fibers, but SC are also involved 
(Mitchell et al., 2004). 
Muscle atrophy can be due to an increase of ubiquitin-proteasome 
activity and a deregulation of autophagy. The proteasome system 
involves ubiquitin ligases, such as MuRF1 and MAFbx/atrogin 1 
which target proteins for degradation. MyoD is included among 
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MAFbx targets, suggesting a regulatory role for ubiquitin-ligases in 
myogenic differentiation, in addition to a catabolic function. MuRF 
induces troponin I, actin and myosin degradation (Clarke et al., 
2007; Cohen et al., 2009; Polge et al., 2011). Autophagy includes 
micro autophagy, lysosome-mediated substrate degradation, 
macro-autophagy induced by fusion of autophagosome with 
lysosomes, and mitophagy, which participates to mitochondrial 
network remodeling.  Multiple pathways affect autophagy, such as 
the IGF1/AKT/FoxO, inflammatory cytokine-dependent NF-kB 
activation, and ActIIBR-dependent signal transduction shared by 
other TGF--family members, such as Activin A and myostatin 
Downregulation of the IGF1/AKT pathway is known to induce 
muscle atrophy. In particular, IGF1 downregulation induces AKT 
dephosphorylation in cancer cachexia (Costello et al., 2006); upon 
this condition, AKT cannot activate the mTOR complex, which, in 
turn, is not able to induce transcription factor activity for protein 
synthesis via phosphor-S6 kinase and EIF4EBP1 (the latter releases 
the initiation factor of traduction, eIF4E). The lack of AKT-
dependent phosphorilation of the transcription factor FoxO1, 3 
and 4, results in the nuclear translocation of these factors, which 
are then able to recognize target genes, such as MAFbx/Atrogin-1 
and MURF1. Moreover, it was shown that FoxO3 is implicated in 
autophagy via the induction of gene expression like LC3 and Bnip3 
(Romanello et al., 2015; Luo et al., 2014). A well known pro-
atrophic pathway is the cytokine dependent NF-kB activation. NF-
kB is maintained in inactive state by a binding with its inhibitor lkB. 
A increase of pro-inflammatory cytokines concentration, in 
particular TNF (Tumor necrosis factor ), activates a kinase IKK 
which phosphorylates IkB, thus promoting its ubiquitinylation and 
degradation. In this way, NF-kB is released and can translocate to 
the nucleus to active the transcription of NF-kB dependent genes 
such as FoxO.  
The role of TGF family members is also well known to play a pivotal 
role in muscle homeostasis. Myostatin and Activin A are able to 
Alexandra BACCAM 
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recognize the Activin A receptor type IIB, which  dimerize with  
receptor type I, Alk4, Alk5 (Activin receptor-like kinase 4 or 5). 
Following dimerization, Alk phosphorylate the complex smad2/3, 
which upon smad4 recruitment translocates to the nucleus and 
represses the transcription of genes implicated in muscle 
differentiation, like the MRFs. In parallel, phosphor-smad2-3 
induces phosphorylation of AKT, which allows FoxO nuclear 
translocation to induce the transcription of atrogenic genes for 
muscle atrophy. 
 
 Hypertrophy is a muscle response to environmental changes 
opposite of atrophy. In fact, the volume of myofiber can increase 
following mechanical cues or alteration of hormonal signalling. 
Hypertrophy is due to an increase of protein synthesis, the 
inhibition of proteolysis, and an increase in satellite cells fusion 
with myofibers.  
The IGF1/AKT/mTOR pathway plays a primary role in muscle 
hypertrophy. In fact, IGF-1 activates the PI3K/AKT pathway. AKT 
activates mTOR by the formation of mTOR/raptor, complex which, 
in turn, activates phosphor-S6 kinase and EIF4EBP1, ultimately 
leading to increase protein synthesis. In fact, EIF4EBP1 releases 
eIF4E, as initiator of traduction factor. Furthermore, AKT represses 
GSK3Glycogen Synthase Kinase 3), which inhibits the initiator 
of traduction factor eIF2B. In addition, AKT phosphorylates 
transcription factors of the FoxO family, thus hampering their 
translocation in nuclei and repressing the transcription of 
atrogenic genes. 
Follistatin (Fst) is a TGF family member, whose principal function is 
the inhibition of myostatin and Activin A.  Fst is an autocrine 
glycoprotein secreted by skeletal muscle (Hansen et al., 2016). In 
human, 2 isoforms of follistatin, Fst288 and Fst315, are the tissular 
and circulating forms, respectively. Fst can sequester Activin A and 
myostatin and prevents their interaction with Activin IIB receptor 
(ActIIBR). Fst has an affinity for Activin A of 1,7nM and for 
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myostatin of 12.3nM (Cash et al., 2009). So Fst counteracts muscle 
atrophy by preventing primarily Activin A as well as myostatin, 
from recognizing the Activin IIB receptor. Thus the downstream 
activation of the complex smad2/3 is not triggered by 
phosphorylation. Ultimately, smad2/3 remains in the cytoplasm 
and cannot repress MRFs expression.  
From the aforementioned pathways, it is evident that extensive 
cross-talk exists among different pathways, which are mutually 
exclusive, leading to atrophy or hypertrophy. 
 
2. Cancer effects on muscle mass 
 
A tumor secretes many circulating factor promoting muscle 
wasting, like pro-inflammatory cytokines, but chemotherapy 
commonly used against cancer also negatively affects  muscle 
mass, independently of tumor mass (Damrauer et al., 2008) adding 
up atrophying effects. Many studies demonstrate toxicity effects of 
chemotherapy per se, which worsens cancer cachexia in cancer 
patients (Andreyey et al., 1998).  
 
Cachexia is a multifactorial syndrome associated to a chronic or 
acute disease like cancer and characterized by a body weight loss 
of at least 5% in one year on presence of illness and at least three 
of the following criteria: decreased muscle strength, fatigue, 
anorexia and abnormal biochemistry.  
Indeed muscle atrophy is associated to muscle strength loss, due 
to sarcomere degradation in the myofibers. Anorexia may or may 
not be associated to cachexia; however, it further decreases 
muscle mass by a lack of nutriment to support protein 
homeostasis. When a patient enters this vicious cycle, fatigue 
contributes to further diminish physical activity and, thus, 
Alexandra BACCAM 
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contributes to muscle atrophy exacerbation, with negative 
consequences on the patient's quality of life. 
 
Cancer cachexia is characterized by an increased level of pro-
inflammatory cytokines, such as Tumor necrosis factor  (TNF), 
Interleukin 6 (Il-6), Interferon (IFN), due to secretion by the tumor, 
but also because of immune system and treatment reaction of the 
patients. In respect to myofibers much less known are the effects 
of the tumor on muscle stem cells. It was shown that the number 
of satellite cells increases in cachexia but their myogenic potential 
is inhibited in vivo in cachectic mice (He et al., 2013). This occurs in 
spite of the fact that satellite cells keep their myogenic 
differentiation capacity in vitro. This suggests that the 
microenvironment inhibits myogenic differentiation of satellite 
cells in vivo. It was shown that ratio between Pax7 and MyoD 
increases in cachexia, with Pax7 being inhibitory for satellite cell 
differentiation and muscle regeneration. NFkB is transcriptional 
factor which plays a role in proliferation, renewal and survival of 
cell (Peterson et al., 2011). In cancer cachexia, it was shown that  
high NFkB activity mediated Pax7 dysregulation (He et al., 2013) 
and inhibited myogenic differentiation likely by decreasing in vivo 
and in vitro MyoD RNA levels (Guttridge et al., 2000). Thus, in 
cachexia, NFkB activity increases and keeps satellite cells in an 
undifferentiated state, increases Pax7 expression, induces 
decrease of MyoD RNA   and participates to protein degradation by 
increasing FoxO expression. Consistently, many studies 
demonstrated that NFkB activity is induced inflammatory factors 
like TNF, angiotensin II (Ang II), TGF family members, as well as by 
Reactive oxygen species (ROS), which are increased in cancer 
cachexia. For what concerns the anti-differentiative and pro-
catabolic effects of cytokines, many studies showed that TNF is 
sufficient to induce myotube atrophy in vitro (Miller et al., 1988) 
and myofiber atrophy in vivo (Langen et al., 2006); in addition, TNF 
inhibits muscle regeneration (Coletti et al., 2005). Some groups 
showed that TNF activates NFkB activity to block muscle 
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regeneration (Guttridge et al., 2000; Ladner et al., 2003), while 
others  demonstrated the implication of a p53 cell death pathway 
including PW1/Peg3, Pax- and caspases-dependent signaling 
downstream TNF (Moresi et al., 2008; Schwarzkopf et al., 2006). 
In cachexia, IL-6 level also increases, and many studies in vivo and 
in vitro demonstrated IL-6 activates JAK/STAT3 (Pelosi et al., 2014; 
Bonetto et al., 2012). Additional pathways downstream of IL-6 are 
the ERK and PI3K/AKT pathways (Munoz et al., 2013 and Zhang et 
al., 2013). In vitro studies show that IL-6 impairs myogenic 
differentiation by modulation of p90RSK/eEF2 and mTOR/p70S6K 
(Pelosi et al., 2014).  
 Ang II increases in animal model of cancer cachexia by inhibition of 
angiotensin converting enzyme (Sanders et al., 2005). An increase 
of Ang II in the microenvironment of satellite cells induces the 
activation of smad2/3 which plays a catabolic function by blockage 
of AKT/ m TOR signaling (Rommel et al., 2001). A study showed a 
further, intriguing link between Ang II and NFkB activation (Ruiz-
Ortega et al., 2000), even though this was not in the context of 
cancer cachexia. 
The smad2/3 complex can also be involved in response to increase 
levels of TGF family member, such as Myostatin. The latter inhibits 
MyoD expression in satellite cells (Langley et al., 2002). Elevated 
levels of myostatin and Activin A, TGF family members secreted by 
muscle and tumor (Chen et al., 2014; Han et al., 2013), correlate 
with cancer patients who develop cachexia (Bonetto et al., 2009; 
Chacon-Cabrera et al., 2014; Zhou et al., 2010). A study showed 
that myostatin gene inactivation prevents the severe loss of 
skeletal muscle mass in Lewis Lung carcinoma bearing mice. The 
inactivation of myostatin also reduced the growth of LLC tumors 
and increased survival of tumor bearing mice. This rescue can be 
explained by a decrease of genes expression involved in tumor 
metabolism and Activin signalling, thus a reduction of apoptosis 
activity (Gallot et al., 2014).  
Alexandra BACCAM 
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Other studies in tumor bearing mice have also demonstrated that 
the administration of Activin IIB Receptor preserves skeletal muscle 
mass (Benny Klimek et al., 2010), restores muscle strength 
(Busquets et al., 2012) and increases lifespan (Zhou et al., 2010). 
Targeting ActIIBR ligands can also affect Activins, including Activin 
A (Zhou et al., 2010). From the all above, it is clear that TGF family 
members have a key role in cancer cachexia; therefore, TGF family 
members response to physical exercise and a modulation of their 
concentration may affect and counteract cancer cachexia via 
training exercise.  
 
3. Exercise effect on cancer cachexia 
 
In clinical practice a multimodal intervention is often used against 
cachexia, based on the following main axes: nutritional support, 
appetite stimulants, anti-inflammatory agents, stimulation of pro-
anabolic pathways and physical exercise. However, physical 
activity was proven sufficient for a positive clinical effect on 
survival and lifestyle on cancer patients. 
 
 3.1 Benefit of exercise practice during cancer cachexia 
Recently, it was shown in tumor-bearing mice performing wheel 
running that natural killer cells were recruited to attack the tumor 
and decreased its mass, thus contributing to remove a primary 
cause of cachexia. Nonetheless, it is clear that exercise has direct 
effects on muscle cells and tissues, in both physiological and 
pathological conditions (Pigna et al., 2016; Padilha et al., 2017; 
Aversa et al., 2017). 
Epidemiological studies and one clinical trial showed that physical 
activity that occurs post-diagnosis improves prognosis, rather that 
exercise habits established before disease (breast and colorectal 
cancers): indeed, physical activity after diagnosis lowers the risk of 
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both cancer-specific and overall mortality, ameliorates patients' 
quality of life and increases survival (Holmes et al., 2005; 
Meyerhardt et al., 2006; Irwin et al., 2008; Holick et al., 2008).  
 
 3.2 Molecular pathway involved in exercise response 
It is worth noting that exercise used as a support to medical 
treatments may vary significantly in intensity and metabolic 
impact. Resistance exercise training is defined as multiple 
repetitions of static or dynamic muscular contractions performed 
against a high load or resistance. Resistance training increases 
muscle mass in healthy subjects and attenuates muscle wasting 
associated with ageing. Endurance exercise training consists of 
performing low-to-medium intensity exercise for long periods of 
time. Endurance training (such as running, cycling, or swimming) 
involves the use of several large groups of muscles and tends to be 
aerobic. Adaptations to endurance exercise include improved 
oxygen delivery to muscles and their increased oxidative capacity 
(Hakkinen et al., 2005). 
The IGF1/AKT/FoxO pathway, known to induce muscle 
hypertrophy via protein synthesis and a reduction of protein 
degradation, is activated by both training types. Aerobic exercise 
induces mitochondrial biogenesis via AMPK activity, which, in turn, 
induces PGC1a activation leading to potentiated ATP synthesis.  At 
day 1 after overload, which mimics resistance training, the 
mitogen-activated protein kinase (MEK)/extracellular signal-
regulated kinase (ERK)-dependent pathway is activated.  This 
pathway can activate mTOR to induce protein synthesis. However, 
ERK1/2 are also activated by endurance training via integrins like 
integrins 1 and 7 which form a dimere, a mechanotransductor 
on cytoplasmic membrane.  
Some studies showed that skeletal muscle secretes TGF family 
members in response of exercise.  
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As reported above, follistatin sequesters myostatin and Activin A 
and all are associated with the regulation of muscle growth (Lee et 
al., 2001; Bilezikjian et al., 2004).  The mechanism of regulation of 
exercise induced follistatin secretion is not clear, but it was shown 
that exercise training increased follistatin expression in rat (Guizoni 
et al., 2013; Rashidlamir A et al., 2016). More recently, a study 
demonstrated that liver-dependent follistatin secretion increases 
in response to exercise in humans (Hansen et al., 2016). This is of 
particular relevance due to the key role of follistatin in muscle 
homeostasis and hypertrophy (Sepulveda et al., 2015; Winbanks et 
al., 2012; Zhu et al., 2011). In summary, these results suggest that 
follistatin could be involved in the beneficial effect of physical 
activity. 
Since the maintenance of muscle mass is the primary goal to 
counteract cachexia, resistance training is often preferred to 
endurance exercise. Indeed, while resistance exercise induces an 
anabolic action, endurance exercise stimulates oxidative metabolic 
adaptations with little changes in muscle mass. Resistance exercise 
in healthy conditions stimulates the Akt/mTOR signaling pathway, 
a pathway that was shown to be unaffected or even 
hyperactivated in tumor-bearing animals (Penna et al., 2010), 
suggesting the uselessness of Akt stimulation to prevent muscle 
wasting in cancer cachexia. On the contrary, soft endurance 
exercise might counteract oxidative stress found in experimental 
cachexia (White et al., 2011). Finally, endurance exercise induces 
physiological adaptations resulting in the attenuation of the 
inflammatory response (Gleeson et al., 2011; Argiles et al., 2011). 
For these reasons, while fewer studies are available on endurance 
exercise, the latter can represent an innovative, more efficient 
intervention against cachexia, in respect to resistance exercise. 
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4. Serum response factor 
 
 4.1 SRF expression 
The SRF gene is conserved from drosophila to humans (Affolter et 
al., 1994). The unique SRF gene is located on chromosome 6p2.1 in 
human and 17 in mouse. It has 7 exons separated by 6 introns and 
has 10 607 pair of bases.  The transcription of SRF gene gives rise 
to two messager RNAs of 4,5 and 2,5kb,  containing different 3’ 
non-encoding regions (Chai et al., 2002).  
The SRF protein has 508 amino-acids and a molecular weight of 
67kDa. The N-terminal region contains nuclear localisation signal 
(NLS). The medium region is characterised by the presence of 
MADS domain/MADS box, which contains the dimerisation domain 
of SRF and a DNA fixation domain. In the C-terminal region SRF has 
the domain responsible for transcriptional activity (Chai et al., 
2002; Johansen et al., 1993).  
 
 4.2 SRF target genes 
Upon activation, SRF forms a homodimere and binds the specific 
sequence CC(A/T)GG, called CArG box (Minty et al., 1986; Treisman 
et al., 1987). SRF target genes are characterized by a promoter 
region containing one or many CArG boxes. In humans, almost 300 
genes have a CArG box and are activated by SRF that is about 1% 
of genome (Modak et al., 2010). SRF gene itself has two functional 
CArG boxes in its promoter, thus it is its own target. In addition, 
SRF regulates the expression of immediate early genes (IEG) like c-
fos, junB, erg-1 and erg-2, so called since their expression is quickly 
activated after a given stimulus. These genes regulate other genes 
involved in the cell cycle or coding for growth factors. SRF 
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regulates cell proliferation and growth via IEG. However, some 
studies shown SRF is not necessary for cell proliferation (Fleige et 
al., 2007; Koegel et al., 2009), suggesting a compensatory pathway 
to maintain cell growth in absence of SRF. 
SRF can recognize many genes implicated in the organization and 
architecture of cytoskeletal, such as vinculin, profiling, 
tropomyosin, actinin 1 etc. (Chai et al., 2002; Sun et al., 2006). 
SRF also regulates the expression of genes involved in cell adhesion 
like integrin 1, 5, 9 and 1 (Miano et al., 2007). 
SRF plays a pivotal role in muscle tissues. Indeed, SRF controls the 
expression of numerous muscle genes, including MyoD, actin 1 
(skeletal muscle), myosin heavy chain, myosin light chain, troponin 
and many others (Chai et al., 2002; Sun et al., 2006).  
 
 
 
 Figure 4: Roles of serum Response Factor from Chai J, 2002.  
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4.3 Regulation of SRF activity by Rho/actin/MRTFs 
pathway 
SRF by itself is a low transactivator and it needs coactivators such 
as ternary complex factors (TCF) or Myocardin-related 
transcription factors (MRTFs) to induce the transcription of SRF 
target genes (Cen et al., 2003; Schroter et al., 1990). TCF family 
members are activated via phosphorylation by MAPK like ERK, JNK 
or p38. The phosphorylation of TCF induces the inhibition of 
interaction between it C domain and ETS domain, which, in turn, 
increases DNA affinity (Posern et al., 2006; Yang et al., 1999). TCF 
forms a complex with SRF and a Serum response element (SRE) in 
the promoter of target genes. In this way, the ETS domain 
recognizes an EBS region near of CArG box in promoter of SRF 
target genes. 
MRTFs show high homology with myocardin, another cardiac-
muscle specific SRF cofactor. The two MRTFs, MRTFA 
(MAL/MKL1/SAC) and MRTF-B (MAL16/MKL2), are ubiquitary. 
Their subcellular localization is regulated by actin dynamics. Some 
studies show that MRTFA is localized most of the time in the 
cytoplasm and that stimulation induces its accumulation in the 
nucleus (Miralles et al., 2003). Modulation of actin dynamics 
mediates signal-induced SRF transcriptional activity: stabilization of 
filamentous actin (F-actin) by the actin-binding drug, 
jasplakinolide, is sufficient to activate SRF without extracellular 
stimuli, but overexpression of actin inhibits SRF (Sotiropoulos et 
al., 1999). The Rho family of Ras-related GTPases (RhoA), controls 
the polymerization of the actin cytoskeleton in response to 
extracellular signals, but also myosin-based contractility, focal 
adhesion formation, transformation and cytokineses (Olson et al., 
2010). RhoA regulates formines like mDia and ROCK activity (Rho-
associated protein kinase). mDia controls profiline and stimulate 
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its polymerization. ROCK controls LIMK activity (LIM domain 
kinase), which induces actin polymerisation by repression of 
cofiline activity (Miralles et al., 2003; Pollard et al., 2003, dos 
Remedios et al., 2003). Profilin and cofilin regulate concentration 
of monomeric actin (Globular-actin/G-actin) and transport of G-
actin between nuclei and cytoplasm. In fact, the association of 
cofilin with importin 9 allows the import of monomeric actin in the 
nucleus; on the contrary, interaction between profiling and 
exportin 6 induces G actin exportation to cytoplasm (Dopie et al., 
2012). Striated muscle activator of Rho signalling (STARS) controls 
MRTFA localization directly by actin polymerisation and indirectly 
via the activation of RhoA (Kuwahara et al., 2005; Zheng et al., 
2009). 
 
Since activation of the Rho/actin pathway is sufficient to induce MRTFA 
nuclear import, it is worth knowing monomeric actin binds the RPEL 
(RPxxxEL) domain of MRTFA, which plays the role of nuclear localization 
signal (NLS) (Pawlowski et al., 2010). The importation of MRTFA 
requires importin  and  activity, which is inhibited by monomeric 
actin, due to a modulation of steric conformation of MRTFA which hide 
NLS during actin binding (Hirano et al., 2010). So, when MRTFA binds 
monomeric actin, NLS sequence is hidden for importin, and MRTFA 
cannot be imported in the nucleus. When actin is poorly polymerized, 
the cytoplasmic actin sequesters MRTFA in the cytoplasm (Posern et al., 
2004). In addition, nuclear export of MRTFA is facilitated by nuclear G 
actin binding and nuclear G-actin prevents activation of SRF target 
genes by nuclear MRTFA (Vartiainen et al., 2007). In this manner, the 
actin-MRTFA-SRF circuit permits the specific modulation of gene 
expression, in a synergy with cytoskeletal dynamic (Olson et al., 2010). 
A recent study demonstrated that MICAL-2, an atypical actin-regulatory 
nuclear protein, regulates nuclear actin and promotes the 
depolymerization of nuclear actin upon redox stimuli and facilitates 
MRTFA-SRF-dependent gene expression (Lundquist et al., 2014). SRF 
activity is regulated by actin dynamics via MRTFs and SRF controls at 
the same time the transcription of actin and actin binding protein 
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(ABP), which, in turn, regulate polymerisation and depolymerisation of 
actin (Pipes et al., 2006; Olson et al., 2010). 
 
Figure 6: Regulation of SRF activity by Rho/actin/MRTFs pathway 
 
 
 
4.4 SRF Knock-out in skeletal muscle cells  
SRF is necessary for muscle cell proliferation and differentiation, as 
shown in vitro, by SRF knock-out in the myogenic cell line C2C12, 
by anti-sense RNA (Soulez et al., 1996). Consistently, the inhibition 
of SRF activity in C2C12 by antibodies or by competition with SRE, 
prevents myogenic regulator factor expression, MyoD (Gauthier-
Rouviere et al., 1996). 
SRF knock-out in embryonic skeletal muscle showed that SRF plays 
a key role in skeletal muscle development (Li et al., 2005). A  SRF 
KO model used Cre recombinase dependent of myogenin 
promoter called Myo-Cre, thus SRF KO is possible in skeletal 
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muscle from E9.5 on. Another SRF KO model had Cre expression 
led by creatine kinase promoter (MCK), which  permitted the late 
deletion of SRF In both models, there was a several muscle 
hyperplasia with a fail of hypertrophy capacity in skeletal muscle 
and finally the death of mice during perinatal period (Li et al., 
2005). 
To exclude a role of SRF in early myogenesis, a study with a Myf5-
SRF conditional KO was done. However, this study showed a 
hypotrophic phenotype in Myf5-SRF conditional KO mice similar to 
the one of the MyoD-null mice. Thus, the hypotrophy could be due 
to SRF alteration involved in myogenic differentiation via MyoD. 
MyoD gene contains a SRF binding CArG-like element in distal 
regulatory region (DRR). This sequence is involved in the 
transcriptional activation of MyoD in myoblasts and during muscle 
regeneration (L’honore et al., 2003). MyoD DRR contains a binding 
site for SRF and also for Myocyte Enhancer Factor 2 (MEF2); MEF2 
is a muscle transcription factor which controls myogenic program. 
So MyoD is controlled by both SRF and MEF2.  
In postnatal muscle, muscle-fiber specific SRF deletion under the 
promoter of Human Skeletal Actin-Cre (HSA) induced a severe 
skeletal muscle mass reduction and hampered myogenic 
regeneration (Charvet et al., 2006).  At birth, mice seemed normal 
but at 6 weeks of age 50% of the population died due to muscle 
growth anomaly: null mice displayed very small myofibers with 
larger interstitial space than control mice. Moreover, myofibers 
presented abnormal sarcomeric organisation and an accumulation 
of glycogen (Charvet et al., 2006). A more recent study in a murine 
model with tamoxifen-inducible SRF deletion showed that the 
muscle fiber specific SRF KO blocks hypertrophy due to overload 
and impairs satellite cell proliferation and recruitment to fuse with 
myofibers (Guerci et al., 2012). This work also showed that in 
response to increased workload, myofibers secrete IL-6 and IL-4 in 
a SRF-dependent manner. SRF leads to IL-6 and lL-4 expression via 
Cox2 and induces proliferation of satellite cells and their fusion 
with myofibers ultimately promoting hypertrophy (Guerci et al., 
PhD in Morphogenesis and Tissue Engineering 
                       PhD in Physiology, physiopathology and therapeutics 
 
 25 
2012).  
 
The same laboratory showed that SRF is an important key 
mediator of mechanotransduction in skeletal muscle via the actin-
MRTF-SRF axis. A deletion of MRTFA in satellite cells induces a 
downregulation of MyoD expression (Mokalled et al., 2012). 
Inhibition of this axis induced skeletal muscle atrophy (Collard et 
al., 2014). In addition, this laboratory showed that SRF is not 
indispensable for the MyoD expression and for proliferation of 
satellite cells. Rather, SRF plays an important role in the crosstalk 
between satellite cell and the myofiber.  A recent study 
demonstrated that in myoblasts, the necessity of SRF expression in 
both partners to fuse, is symmetric fusion (unpublished results, 
personal communication) (Figure 9). 
  
 
Surprisingly, a SRF deletion in adult mice does not alter mouse 
phenotype despite a high decrease of SRF until 5 months after 
tamoxifen injection. After this period, a premature ageing is 
observed with a decrease of myofiber size, disorganization of 
sarcomeres, and fast to slow fiber type transition (Lahoute et al., 
2008). Worth nonetheless noting that in human and mouse, SRF 
expression in muscle decreases during ageing (Lahoute et al., 2008, 
Sakuma et al., 2008). 
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OBJECTIVES  
Exercise increases life span in cancer patients and rescues muscle 
homeostasis in animal models of cancer cachexia. Exercise has 
pleiotropic effects, directly affecting the musculoskeletal 
apparatus but also the endocrine, immunological, cardiovascular 
and neurological apparatuses.  In spite of the importance of 
muscle stem cell dysfunction for cachexia that we and others 
contributed to demonstrate, whether exercise directly affects 
muscle cells is not known; in addition, it has never been 
demonstrated whether secreted factors and/or mechanical 
stimulation, both phenomena associated to exercise, mediate 
exercise beneficial effects on muscle cell homeostasis and 
myogenic potential. Acquiring additional information on exercise 
targets would allow to improve exercise-based protocols against 
cancer cachexia.  
Primarily, I strived to determine whether an in vitro model 
(consisting of cocultures of myotubes and myoblasts, in the 
absence or presence of tumor-derived factors) simulate myotube 
atrophy observed in vivo in the presence of cancer. 
The major objectives of this thesis are the following: 
1) To demonstrate whether a purely mechanical treatment is 
sufficient to counteract tumor cell negative effects on myotubes; 
2) To identify which are the paracrine mediators of myoblast 
recruitment to myotubes, if any; 
3) To demontrate SRF regulation and its role in mediating these 
responses. SRF seems to be an important actor of muscle plasticity 
and could play a role to prevent muscle atrophy in cancer cachexia 
by the way of physical exercise. This hypothesis arises from studies 
showing the pivotal role of SRF in muscle homeostasis and in 
interleukin-mediated satellite cell recruitment to myofibers. 
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RESULTS 
 
  5. C26 cell conditioned medium effects on C2C12 myotubes  
 
5.1 C26 cells conditioned medium blocks myotubes 
growth while mechanical stimulation counteracts this 
negative effect 
We established cell cultures containing a mixed population of 
myotubes and unfused myoblasts, obtained by 4d culturing in 
differentiation medium (DM). In the order to study the effects of 
tumor-derived factors on muscle cell culture,   C26 cell conditioned 
medium was obtained and used to treat C2C12 mixed cultures. In 
preliminary experiments, two-day treatment with a DM containing 
20% of C26 conditioned medium (CM) induced myotube atrophy 
and hampered myoblast differentiation (data not shown). Control 
medium or CM were, therefore, used to treat C2C12 mixed 
cultures, in the absence (static condition, SC) or presence (dynamic 
condition, DC) of mechanical stimulation consisting of daily 
sessions of  longitudinal stretch for 6 hours per day, as described in 
M&M (Figure 9). 
Alexandra BACCAM 
______________________________________________________ 
 28 
 
Figure 9: Effects of C26 conditioned medium on myotube growth. (A) 
Immunofluorescence of myosin heavy chain (red) and nuclei (blue) on C2C12 cell 
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cultures: C2C12 are incubated for 4 days in DMEM + 2% HS to obtain a mixed 
culture of myotubes and myoblasts (4 days); additional 2 days culture in DMEM 
+ 2% HS in the absence (2% HS in SC and 2% HS in DC) or presence (2% HS + 20% 
CM in SC and 2% HS + 20% CM in DC) of C26 CM (the latter represents 20% of 
the culture medium) cyclic mechanical stretch is applied as described in M&M 
(Dynamically stretched condition, DC) or not (statically stretched condition, SC), 
2% HS in DC, 2% HS + 20% CM in DC, 2% HS in SC, 2% HS + 20% CM in SC, 
respectively. (B) The percentage of nuclei into myotubes (fusion index) (C) The 
myotube diameter and (D) the myotube nuclear size (number of nuclei per 
myotube) were measured on IF pictures (as in A). n=3. Statistical analysis 
demonstrated a significant effect of cyclic stretch on myotube diameter and a 
significant effect of conditioned medium on the number of nuclei per myotube 
by TWO-WAY ANOVA; For fusion index, by TWO-WAY ANOVA: F=24,73; df=1; 
p<0,001 for conditioned medium, F=30,22; df=1; p>0.001 for interaction; we 
used Tukey post hoc test, # p<0,05, ## p<0.01; For myotube diameter, by TWO-
WAY ANOVA F=12,66; df=1; p>0,05 for cyclic stretch; in absence of interaction 
not able to use Tukey post hoc test to compare every group each others. For the 
myotube nuclear size, by TWO-WAY ANOVA: F=5,64, df=1, p<0,05 for 
conditioned medium in absence of interaction.  
Compared to standard conditions for myogenic differentiation that 
DM we observed atrophic myotubes in presence of C26 cell CM 
determined myotube atrophy, in the absence of mechanical 
stretch, in agreement with what previously reported (Pelosi et al 
2014). When mechanical cues are applied , we observed  myotube 
hypertrophy even in the presence of C26 CM, consisting of a higher 
myotube diameter associated to an increased number of 
myonuclei per myotube and higher fusion index (the percentage of 
nuclei in myotubes on the total number of nuclei) (Figure 9A). In 
particular, CM decreased by twice the fusion index in compared to 
controls and negatively affected myotube diameter; statistical 
analysis demonstrated the significance of these effects (Figure 9B 
and C). Cyclic stretch significantly affected myotube size in terms 
of nuclei per myotube, suggesting that it stimulated nuclear 
incorporation into myotubes, even in the presence of C26 CM, in 
addition to protein synthesis and true hypertrophy (Figure 9D).  
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5.2 Mechanical cues rescue the myogenic differentiation 
program likely via MRFs activation 
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Figure 10: Effects of mechanical cues on myogenic differentiation marker. (A) 
Western-blot of MyoD expression in C2C12 cell cultures. n=3, however each lane 
contains protein extracts representing the pool of 3 independent samples from 
C2C12 cells after 6 days cultures in absence (HS) or presence of C26 CM (CM), in 
the absence (SC) or presence of (DC) of cyclic stretch for the last two days. In 
addition experiments were carried out in triplicate. The columns represent 
average relative intensity of myoD protein expression. Statistic analysis 
demonstrates a significant positive effect of cyclic stretch on MyoD protein 
expression (F=9,47; df=1; p<0,001 for cyclic stretch, absence of interaction by 
TWO-WAY ANOVA). (B) Immunofluorescence of myogenin (red) and nuclei 
(blue). n=6. Columns represent the percentage of myogenin positive nuclei from 
triplicate experiments. Statistic analysis demonstrates a significant positive 
effect of cyclic stretch on the percentage of nuclei which expressing myogenin 
(F=20,61; df=1; p<0.01 for conditioned medium and F= 821,61; df=1; p<0,001 for 
cyclic stretch, absence of interaction by TWO-WAY ANOVA). 
 
The C26 CM-mediated inhibition of myoblast recruitment to 
myotubes does not seem to be associated to an overall decrease 
of MyoD and myogenin expression. However, in presence of cyclic 
stretch, MyoD protein expression and the number of myogenin 
positive nuclei increase significantly in absence or presence of CM. 
That suggests that increased MRF expression mediates its 
beneficial effects, ultimately resulting in myotube growth (Figure 
10). Worth noting that the majority of MRFs RNA expression, 
including MyoD and myogenin, is negatively affected by the 
presence of CM, while cyclic stretch improves the level of RNA 
expression of these genes (Table 1); this confirms that cyclic 
stretch positive effects are associated to increased MRFs 
expression and suggests a certain stability of MyoD and myogenin 
at protein level, in the presence of C26 CM. Anyhow, as a result of 
C26 CM treatment, we observed a significant negative effect on 
myosin heavy chain (myh7) RNA expressions that demonstrated a 
late inhibition of the myogenic program, an effect counteracted by 
cyclic stretch. 
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1.06 +/-0.080.82 +/-0.101.72 +/-0.301.06 +/-0.090.82 +/-0.07CM DC
1.38 +/-0.160.87 +/-0.091.69 +/-0.280.93 +/-0.120.73 +/-0.07HS DC
0.70 +/-0.100.49 +/-0.061.19 +/-0.140.82 +/-0.090.54 +/-0.04##CM SC
1.39 +/-0.110.82 +/-0.091.59 +/-0.151.00 +/-0.140.70 +/- 0.03 #HS SC
Myh7
(type I fibers)
myogeninMRF4Myf5MyoD
Table 1: Comparison by Q-PCR of MRFs expression implicated in myogenic 
differentiation. Gene expressions, normalized by GAPDH and expressed as fold-
change over the expression after 4 days of myogenic differentiation in horse 
serum 2%. C2C12 are incubated for 4 days in DMEM + 2% HS to obtain a mixed 
culture of myotubes and myoblasts; additional 2 days culture in DMEM + 2% HS 
in the absence (HS SC and HS DC) or presence (CM SC and CM DC) of C26 CM 
(the latter represents 20% of the culture medium) cyclic mechanical stretch is 
applied as described in M&M (Dynamically stretched condition, DC) or not 
(statically stretched condition, SC), HS DC, CM DC, HS SC, CM SC, respectively. 
.n=12. Statistical analysis (TWO-WAY ANOVA) demonstrates a positive effect of 
cyclic stretch on MyoD (F=6,58; df=1; p<0,01) and myogenin (F=4,42; df=1; 
p<0,05) gene expressions. Statistical analysis (TWO-WAY ANOVA) demonstrates 
a negative effect of C26 conditioned medium on myh7 (F=14,87; df=1; p<0,001) 
and myogenin (F=3,97; df=1; p<0.05) gene expressions. TWO-WAY ANOVA 
shows an interaction on MyoD (F=4,38; df=1; p<0,05) gene expression, which 
allows Tukey post hoc test #, p<0.01 between HS SC and CM SC, ## p<0.01 
between CM SC and CM DC.  
 
6. C26 cells conditioned medium and mechanical cues affect 
myogenic differentiation   by modulating secreted factors 
 
6.1 Mechanical cues restore Activin A and Follistatin 
balance favouring myogenic differentiation 
With the aim to identify potential mediators of cyclic stretch 
beneficial effects against C26 CM, we investigated the secretion of 
protein known to be involved in myotube growth, such as TGF 
family members. Surprisingly, we found that Myostatin 
concentration decreased in the presence of CM, and increased in 
the presence of cyclic stretch independently of CM (Figure 11A). 
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This result was unexpected, knowing that myostatin is an atrophic 
factor which plays a key role in muscle homeostasis, blocking its 
growth; however, this result was observed at the point of the 
experiment, i.e. at day 6, when the final effects of the treatments 
were already achieved: the implications of this unexpected finding 
will be further discussed. 
We also observed that C26 CM induced a high concentration of 
Activin A in the supernatant of C2C12 cultures after 6 days 
suggesting that C26 cells could inhibit myogenic differentiation by 
an activation of the Activin receptor 2B. Intriguingly, the Activin A-
inhibitor follistatin (Fst) decreased in the same conditions, further 
suggesting a role for this pathway in the control of myotube size. 
In the presence of cyclic stretch, not only Activin A concentration 
in the supernatant is lowered, but also, quite surprisingly, 
follistatin concentration decreases (Figure 11B). However, since 
physiologically relevant is the ratio of follistatin on Activin A, the 
latter was calculated for the different experimental conditions. The 
ratio decreases dramatically in static condition in presence of CM, 
while in the presence of cyclic stretch, the ratio increases 
significantly in respect to CM alone, suggesting a potential rescue 
of myogenic differentiation and myotube homeostasis by cyclic 
stretch; the fact that the follistatin/Activin A ratio never reaches 
control levels in the presence of cyclic stretch suggests that 
mechanical cues have an effect on this ratio, likely acting on both 
follistatin and Activin levels (Figure 11C).  
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Figure 11: Comparison of TGF family member secretion on C2C12 supernatant. 
Myostatin (A), Activin A and follistatin (B) concentration (pg/mL) in supernatant 
by ELISA on C2C12 supernatant. C2C12 are incubated for 4 days in DMEM + 2% 
HS to obtain a mixed culture of myotubes and myoblasts; additional 2 days 
culture in DMEM + 2% HS in the absence (HS SC and HS DC) or presence (CM SC 
and CM DC) of C26 CM (the latter represents 20% of the culture medium) cyclic 
mechanical stretch is applied as described in M&M (Dynamically stretched 
condition, DC) or not (statically stretched condition, SC), HS DC, CM DC, HS SC, 
CM SC, respectively. n=10. Statistical analyses demonstrated a significant effect 
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of conditioned medium (F=101,11; df=1; p<0,0001), of cyclic stretch (F=70,77; 
df=1; p<0,0001) on myostatin concentration (A) by TWO-WAY ANOVA. In 
addition a significant interaction (F=9,66; df=1; p<0,01) permit to use Turkey 
post hoc test (## p<0,001).  Statistical analyses (TWO-WAY ANOVA) 
demonstrated a significant effect of condition medium on Activin A 
concentration (F=19,71; df=1; p<0,001) by an interaction (F=35,42, df=1; 
p<0.001) permitted to use Tukey post hoc test (## p<0,01). Statistical analyses 
(TWO-WAY ANOVA) also demonstrated a signicant interaction (F=5,95; df=1; 
p<0,05) which permitted to use Tukey post hoc test (## p<0,01) (C) Follistatin on 
Activin A ratio was calculated with Follistatin and Activin A concentration 
(pg/mL) (B) Statistical analyses (TWO-WAY ANOVA) demonstrated a significant 
effect of conditioned medium on the ratio (F=17,02; df=1; p<0.001), a also a 
significant interaction (F=38,65; df=1; p<0,0001) permitted to use Tukey post 
hoc test (## p<0,01). 
 
To confirm the modulation of ActIIBR downstream pathways, the 
ratio between phospho-smad2-3 and total smad2-3 was quantified 
in the different conditions. In particular, C26 CM increased smad2-
3 phosphorylation in respect to controls, while mechanical stretch 
rescued smad activation.  
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Figure 12: Effects of treatments on smad2-3 phosphorylation in presence of 
C26 CM. A) Western-blot of total and phosphorylated smad2-3 in C2C12 cell 
cultures. Each well contains protein extracts representing the pool of 3 samples 
from C2C12 cells after 6 days cultures in absence (HS) or presence of C26 CM 
(CM), in the absence (SC) or presence of (DC) of cyclic stretch for the last two 
days. In addition experiments were carried out in triplicate. The columns 
represent average relative intensity of smad2-3 total and phospho-smad2-3 
protein expression. B) Columns represent the ratio of phosphorylated smad2-3 
on smad2-3 total protein blot densities. TWO-WAY ANOVA demonstrates a 
significant effect of conditioned medium (F=46,44; df=1; p<0,0001), cyclic 
stretch (F=6,25; df=1; p<0,01), interaction (F=12,36; df=1; p<0.001). The latter 
permitted to use Tukey post hoc test, #p<0,05, ##p<0,01. 
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6.2 Follistatin is not sufficient to counteract myotube 
atrophy due to conditioned medium 
To determine if follistatin is sufficient to restore the total myogenic 
capacity in presence of C26 CM, 4 d C2C12 cultures were treated 
with recombinant follistatin for 2 days, in the absence of 
mechanical stimulation. Preliminary data limited to three samples 
confirmed the negative effects of C26 CM compared to standard 
conditions, an effect not rescued by recombinant follistatin, 
regardless the parameter examined (Figure 13A-D).  Based on the 
trend observed in figure 13B, we cannot exclude that follistatin per 
se might rescue fusion index, i.e. myogenic differentiation even in 
the presence of C26 CM.  However, this pathway only contributes 
to the rescue of myotube homeostasis, since follistatin is definitely 
not sufficient to counteract C26 CM negative effects on myotube 
diameter or nuclear number.  
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Figure 13: Effects of follistatin on C2C12 mix culture in presence of CM. (A) 
Immunofluorescence  of myosin (green) and nuclei (blue) on C2C12 cell cultures, 
following 4 days in DMEM + 2% HS and additional 2 days  in DMEM + 2% HS in 
absence (HS SC) or presence (CM SC, CM SC+FST) of C26 CM in statically 
stretched condition (SC); recombinant follistatin (FST 100ng/mL) was added in 
combination with CM. (B) The percentage of nuclei into myotubes (fusion 
index), (C) The myotube diameter and (D) the myotube nuclear size (number of 
nuclei per myotube) were calculated on IF pictures . n=3; **, p<0.01 by ONE-
WAY ANOVA (for myotube diameter F=28,92, df=2, p<0,001; for number of 
myonuclei, F=22,93, df=1, p<0,001) followed by Tukey post hoc test,  
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7. SRF activity counteracts the negative effect of C26 cells 
conditioned medium on myogenic differentiation 
 
7.1 Mechanical cues activate the Rho/actin/MRTFs 
pathway 
We have shown that an increase in the follistatin/Activin A ratio 
could counteract myotube atrophy, even though it is not sufficient 
for a full restoration of myotube homeostasis in the presence of 
CM. For this reason, we explored another pathway, which is 
directly stimulated by mechanical cues in skeletal muscle and has 
been shown to recruit satellite cells to myofibers via IL-4: the 
Rho/actin/MRTFs pathway involving SRF transcriptional activity.  
A precocious sensor of mechanical stretch in muscle is Striated 
Activator of RhoA signalling (STARS). The latter is localized on 
sarcomeric actin and responds to mechanical cues on the actin 
network by an induction of F-actin polymerisation. Indeed, we 
found that STARS RNA was downregulated by C26 CM, but cyclic 
stretch counteracts this effect and induces STARS expression to 
higher levels even compared to controls (Figure 14A). STARS 
regulates localization of the SRF cofactor MRTF-A via RhoA. Indeed, 
RhoA RNA expression was significantly upregulated by cyclic 
stretch associated to a similar modulation of RhoA protein   (Figure 
14B and 14C). Since STARS and RhoA activation induce actin 
polymerization, we purified monomeric and filamentous actin and 
calculated the F-actin to G-actin ratio, in the various experimental 
conditions.  We observed a significant effect of cyclic stretch on F- 
to G-actin ratio, suggesting actin polymerisation in response to 
cyclic stretch both in presence and absence of C26 CM (Figure 
14D).  
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Figure 14: Analysis of the STARS/RhoA/Actin axis in C2C12 cultures. (A) STARS 
and RhoA gene expression normalized by GAPDH and expressed as fold-change 
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over cell cultures after 4 days of myogenic differentiation in horse serum 2%. 
C2C12 are incubated for 4 days in DMEM + 2% HS to obtain a mixed culture of 
myotubes and myoblasts; additional 2 days culture in DMEM + 2% HS in the 
absence (HS SC and HS DC) or presence (CM SC and CM DC) of C26 CM (the 
latter represents 20% of the culture medium) cyclic mechanical stretch is 
applied as described in M&M (Dynamically stretched condition, DC) or not 
(statically stretched condition, SC), HS DC, CM DC, HS SC, CM SC, respectively.  
n=12. Statistical analysis (TWO-WAY ANOVA) demonstrates significant effect of 
cyclic stretch (F=24,02; df=1; p<0,0001) and an interaction (F=6,09; df=1; p<0,01) 
on STARS gene expression. The interaction permits to use Tukey post hoc test (# 
p<0,05; ## p<0,01). TWO-WAY ANOVA demonstrates a significant effect of cyclic 
stretch (F=9,38; df=1; p<0,01) on RhoA gene expression in absence of 
interaction. (B) Western-blot of RhoA protein in C2C12 cell cultures. n=3, 
however each well contains protein extracts representing the pool of 3 samples 
from C2C12 cells after 6 days cultures in absence (HS) or presence of C26 CM 
(CM), in the absence (SC) or presence of (DC) of cyclic stretch for the last two 
days. In addition experiments were carried out in triplicate. The columns 
represent average relative intensity of RhoA protein expression. Statistic 
analysis (TWO-WAY ANOVA) demonstrates a significant positive effect of cyclic 
stretch (F=20,72; df=1; p<0,001) on RhoA protein expression. (C) Western-blot 
of Filamentous actin (F-actin) and Globular actin (G-actin) protein expression in 
C2C12 cell cultures.  Columns represent the ratio between F-actin and G-actin 
protein expression. Statistic analysis (TWO-WAY ANOVA) demonstrates a 
significant positive effect of cyclic stretch (F=9,59; df=1; p<0,001) on this ratio.  
 
7.2 MRTF-A translocation to the nucleus is stimulated by 
mechanical cues 
An expected output of STARS/RhoA/actin pathway activation is 
MRTF-A translocation to the nucleus. Given the major role played 
by MRTF-A as SRF transcriptional cofactor, we decided to look in 
detail the regulation of MRTF-A expression and activity. We found 
that MRTF-A RNA is upregulated in presence of cyclic stretch 
independently of CM presence (Figure 15A). To verify if the 
increased MRTF-A expression could resultat in nuclear 
accumulation of this important pro-myogenic transcription co-
factor, we infected C2C12 cultures at 4 days with an adenovirus 
overexpressing MRTF-A in association with GPF. By using this 
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approach, we observed that C26 CM prevented MRTFA localization 
in the myonuclei, and that the presence of mechanical cues 
induced nuclear translocation of MRTF-A, irrespective of any C26 
CM treatment. The percentage of MRTF-A positive nuclei increased 
strongly up to 70% of the myonuclei of infected myotubes, 
suggesting that mechanical cues are a major regulator of MRTF-A 
activation (Figure 15B).  
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Figure 15: MRTF-A expression on C2C12 cultures after 6 days. (A) MRTF-A gene 
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expression by Q-PCR; Gene expression is normalized by GAPDH and expressed 
as fold-change over the expression after 4 days of myogenic differentiation in 
horse serum 2% (4 days). C2C12 are incubated for 4 days in DMEM + 2% HS to 
obtain a mixed culture of myotubes and myoblasts; additional 2 days culture in 
DMEM + 2% HS in the absence (HS SC and HS DC) or presence (CM SC and CM 
DC) of C26 CM (the latter represents 20% of the culture medium) cyclic 
mechanical stretch is applied as described in M&M (Dynamically stretched 
condition, DC) or not (statically stretched condition, SC), HS DC, CM DC, HS SC, 
CM SC, respectively. n=12. Statistic analysis (TWO-WAY ANOVA) demonstrates a 
significant positive effect of cyclic stretch (F=6,08, df=1, p<0,01) on MRTF-A gene 
expression. (B) Infection of C2C12 cultures at 4 days with Adenovirus-MRTF-A-
GFP; MRTF-A GFP expression (green) and nuclei (blue); MRTF-A-GFP positive 
nuclei (blue arrow); MRTF-A-GFP negative nuclei (orange arrow). Columns 
represent the percentage of MRTFA-GFP positive nuclei. n=3. Statistic analysis 
(TWO-WAY ANOVA) demonstrates a significant negative effect of condition 
medium (F=14, df=1, p<0,001) and positive effect of cyclic stretch (F=284,06; 
df=1; p<0,0001) in absence of interaction on the percentage of MRTFA-GFP 
positive nuclei. 
 
7.3 SRF expression increases in presence of mechanical 
cues 
We observed that SRF RNA and protein expression are both 
upregulated in response to mechanical cues, which is in agreement 
with the literature (Figure 16A).  
This prompted us to look at known targets of SRF/MRTF-A 
transcription complex. We decided to focus on IL-4 concentration 
in supernatant of C2C12 culture in response to treatments, since 
IL-4 was previously shown to mediate myoblast recruitment in 
response to SRF activation. As expected, we found a significant 
increase of IL-4 concentration in the supernatants in response to 
mechanical stretch, independently of the presence of C26 CM 
(Figure 16B). This suggested that IL-4 is secreted by myotubes in 
response to workload via SRF activity.  Integrin 1 is a direct SRF 
target gene and we found that integrin RNA expression is also 
significantly upregulated in presence of cyclic stretch with or 
without CM (Table 2). Interestingly, integrin forms a dimer with 
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integrin 7, and this dimer is a mechanoreceptor which mediates 
mechanical cues inside muscle cells.  
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Figure 16: SRF expression and transcriptional activity. (A) SRF gene expression 
is normalized by GAPDH and expressed as fold-change over the expression after 
4 days of myogenic differentiation in horse serum 2% (4 days). C2C12 are 
incubated for 4 days in DMEM + 2% HS to obtain a mixed culture of myotubes 
and myoblasts; additional 2 days culture in DMEM + 2% HS in the absence (HS 
SC and HS DC) or presence (CM SC and CM DC) of C26 CM (the latter represents 
20% of the culture medium) cyclic mechanical stretch is applied as described in 
M&M (Dynamically stretched condition, DC) or not (statically stretched 
condition, SC), HS DC, CM DC, HS SC, CM SC, respectively. n=12. Statistic analysis 
demonstrates a positive effect of cyclic stretch (F=15,56; df=1; p<0,001) on SRF 
gene expression.; Western-blot of SRF protein in C2C12 cell cultures. n=3, 
however, each well contains protein extracts representing the pool of 3 samples 
from C2C12 cells after 6 days cultures in absence (HS) or presence of C26 CM 
(CM), in the absence (SC) or presence of (DC) of cyclic stretch for the last two 
days. In addition experiments were carried out in triplicate. The columns 
represent average relative intensity of SRF protein expression. Statistic analysis 
(TWO-WAY ANOVA)demonstrates a significant positive effect of cyclic stretch 
(F=47,10; df=1: p<0,001) on SRF protein expression. (B) IL-4 concentration in 
C2C12 culture supernatants by ELISA. n=10.  Statistic analysis (TWO-WAY 
ANOVA) demonstrates a significant positive effect of cyclic stretch (F=11,1; df=1; 
p<0,01) on IL-4 concentration in absence of interaction. (D) Western-blot of 
Integrin 7 protein expression in C2C12 cell cultures n=3, however, each well 
contains protein extracts representing the pool of 3 samples from C2C12 cells. 
TWO-WAY ANOVA demonstrates a significant effect of cyclic stretch (F=136; 
df=1; p<0,0001) with an interaction (F=24; df=1; p<0,001) permitting Tukey post 
hoc test (## p<0,001.   
The analysis of the expression of additional SRF target genes  
showed that Cox2 and vinculin expressions is  downregulated by 
the presence of C26 CM, an effect significantly counteracted by 
mechanical cues (Table 2).  
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0.44 +/-0.120.83 +/-0.060.66 +/-0.040.67 +/-0.200.91 +/-0.13CM DC
0.24 +/-0.10**0.99 +/-0.100.89 +/-0.050.93 +/-0.041.00 +/-0.17HS DC
0.11 +/-0.03##0.64 +/-0.070.59 +/-0.090.47 +/-0.030.93 +/-0.16CM SC
0.10 +/-0.07*0.96 +/-0.070.83 +/-0.070.67 +/-0.061.11 +/-0.13HS SC
Integrin 7Integrin 1vinculincox2Sk actin
 
Table 2: Comparison by Q-PCR of SRF target gene expression. Gene 
expressions, normalized by GAPDH and expressed as fold-change over the 
expression after 4 days of myogenic differentiation in horse serum 2%. C2C12 
are incubated for 4 days in DMEM + 2% HS to obtain a mixed culture of 
myotubes and myoblasts; additional 2 days culture in DMEM + 2% HS in the 
absence (HS SC and HS DC) or presence (CM SC and CM DC) of C26 CM (the 
latter represents 20% of the culture medium) cyclic mechanical stretch is 
applied as described in M&M (Dynamically stretched condition, DC) or not 
(statically stretched condition, SC), HS DC, CM DC, HS SC, CM SC, respectively. 
n=12. Statistical analysis (TWO-WAY ANOVA) demonstrates a positive effect of 
cyclic stretch on cox2 (F=23,31; df=1; p<0,001),Integrin 7 (F=10,81; df=1; 
p<0,001) gene expressions. Statistical analysis  (TWO-WAY ANOVA) 
demonstrates a negative effect of C26 conditioned medium on cox2 (F=22,75; 
df=1; p<0,0001), Vinculin (F=15,06; df=1; p<0,001), Integrin b1 (F=10,59; df=1; 
p<0,01) gene expression TWO-WAY ANOVA also demonstrates an interaction on 
integrin a7 (F=5,14; df=1; p<0,05) gene expression which allows to apply Tukey 
Post hoc test: *, p<0.05 between HS SC and CM DC, ** p<0.05 between HS DC 
and CM DC, ## p<0.01 between CM SC and CM DC.  
 
7.4 A knock-down of SRF is sufficient to block the 
myogenic differentiation rescue associated to mechanical 
cues 
 
In the order to determine is SRF is necessary to fully counteract the 
negative effects of C26 CM on C2C12 myotubes in response to 
dynamic stretch, we performed a transfection of siRNA against SRF 
RNA to perform a loss of function experiment. The extent of SRF 
inhibition was measured and is reported in figure 17D.The 
inhibition of SRF expression in dynamic conditions in presence of 
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CM prevented the rescue by mechanical cues: indeed we noticed a 
decrease in the fusion index and myotube size in the absence and 
in the presence of C26 CM in presence of cyclic stretch (Figure 
17A). This confirmed that mechanical cues capacity to counteract 
the effects of CM was dependent on SRF expression (Figure 17B 
and C). All together, these data indicated that SRF is necessary 
rescues myogenic differentiation, even though it does not 
necessarily participate in myotube hypertrophy in response to 
mechanical cues. 
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Figure 17: SRF Knock-down on C2C12 mix culture in presence of statically 
stretched condition. (A) Immunofluorescence of myosin (red) and nuclei (blue) 
on C2C12 cell cultures: C2C12 are incubated for 4 days in DMEM + 2% HS to 
obtain a mix culture of myotubes and myoblasts; additional 2 days culture in 
DMEM + 2% HS in absence (HS SC) or presence (CM SC, CM SC+siRNA-SRF) of 
C26 CM (the latter represents 20% of the culture medium) in dynamically 
stretched condition (DC). (B) The percentage of nuclei into myotubes (fusion 
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index). The myotube diameter were calculated on IF pictures (A). (C) siRNA-SRF 
efficiency is quantified by Q-PCR on C2C12 mix cultures at 6days on plastic 
plates. n=3; **, p<0.01 (ONE-WAY ANOVA followed by Tukey post hoc test 
F=42,38, df=2, p<0,001). 
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DISCUSSION 
 
Previous works demonstrated that physical exercise prevents 
muscle wasting in cancer cachexia (Pigna et al., 2016; Padilha et al., 
2017; Aversa et al., 2017; Holmes et al., 2005; Meyerhardt et al., 
2006; Irwin et al., 2008; Holick et al., 2008). Additional studies 
showed a several increase of Activin A in plasma of cancer patient 
(Bonetto et al., 2009; Chacon-Cabrera et al., 2014; Zhou et al., 
2010; Chen et al., 2014; Han et al., 2013). While other studies 
showed evidences the pivotal role of SRF in muscle plasticity and in 
muscle hypertrophy in response to workload (Guerci et al., 2012). 
Therefore, we wanted to determine if SRF is involved in the 
prevention of muscle atrophy due to factors of possible tumor 
origin, such as Activin A or myostatin. Our in vitro model of 
myotubes/myoblast mixed cultures treated with a tumor CM, and 
subjected or not to mechanical stretch, allowed us to control and 
separate the effects of chemical factors from those depending on 
mechanical stimulation and to evaluate the contribution of each 
pathway in the rescue of myotube. 
 
Activin A is involved in the atrophy of myotubes by activation of 
smad2-3 pathway. 
Myostatin is an atrophying factor and the regulation of its 
expression and secretion seemed to be an ideal candidate 
mechanism to explain both the negative effects of C26 CM and the 
exercise-mediated rescue. Surprisingly, we observed an increase of 
myostatin concentration in the supernatant in dynamic stretched 
condition, which was paradoxal response. We explain, the increase 
of myostatin concentration in presence of cyclic stretch by  the fact 
that , myostatin is secreted by the myofibers themselves in a mass 
dependent manner (to block the increase of myofiber and limit an 
over response of myofibers to mechanical stimuli as it occurs in 
vivo); in conditions of increased myotube mass, such as upon 
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dynamic stretch, we think that these hypertrophic myotube 
secrete a higher amount of myostatin, independently of the 
presence of other factors present in the C26 CM. Differently form 
myostatin, Activin A concentration in the cell supernatant 
increased in response to the presence of CM. In fact, an increase of 
Activin A concentration induces an inhibition of myoblast 
differentiation in skeletal muscle (Trendelenburg et al 2012). In 
agreement, the C26 CM and mechanical cues differentially 
regulated Activin A concentration, suggesting the importance of-
dependent pathways ActIIBR. When we put the concentration of 
follistatin in the picture, we found that secretion of follistatin 
decreased in presence of CM and increased upon mechanical 
stretch. We calculated Follistatin/Activin A ratio. By taking into 
account the information that Fst and Activin A are an affinity to 
Kd=1,7nM (Cash et al., 2009), when the ratio is down to 1,7; the 
activity of ActIIBR go to myogenic inhibition , and more the ratio is 
high, more myogenic activation is induced. Thus, we found that 
this ratio increases strongly in presence of stretch, suggesting that 
the Activin A present in the C26 CM could be inhibited by a very 
significant increased in follistatin. In agreement, in the presence of 
C26 CM, we observed a high phosphorylation of smad2-3, showing 
the actual activation of ActIIBR by factors secreted by tumor cells. 
Mechanical cues may prevent the activity of phosphorylated 
complex smad2-3, ultimately resulting in the promoter of smad 
target genes like myoD, myogenin and others MRFs involved in the 
progression of the myogenic program. We had conscience that 
cachexia is a multifactoral syndrome which is generated by 
multifactors. Theses results permit to say that skeletal muscle 
atrophy uses ActIIBR, which phosphorylates smad2-3 complex and 
inhibits myogenic program. Thus, mechanical stretch counteracts 
CM effects and generates a decrease of smad2-3 activity even in 
presence of CM, which could suggest a response to mechanical 
stretch via this molecular pathway. With the aim to clarify whether 
this molecular pathway is sufficient for the prevention of myotube 
atrophy, we treated C2C12 cultures with recombinant follistatin. 
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Surprisingly, the addition of follistatin on C2C12 cultures did not 
significantly improve the fusion index and the myotubes size was 
not affected by follistatin supplementation. 
Based on the all above, mechanical stretch seems to have a benefit 
effect to counteract atrophic effect induced by Activin A by 
increasing follistatin concentration as compared to static stretched 
conditions. Worth noting, it was shown that C26 cell conditioned 
medium presents cytokines secreted by tumor like TNF- and IL-6, 
which, in turn, induce Activin A secretion by skeletal muscle 
(Trendelenburg et al 2012). 
 
SRF plays a role in mechano-transduction in response to cyclic 
stretch. 
We demonstrated that mechanical cues induce an increase of SRF 
protein expression. C26 CM seemed to not alter SRF expression 
and function in our experimental model, and only mechanical cues 
increased SRF expression and activity, supporting the notion that 
SRF is a transcriptional factor, which is activated in the presence of 
mechanical stimulation. Its co-factor MRTF-A increased too in 
presence of mechanical stimuli and translocated to myonuclei, 
likely promoting the transcriptional activity of SRF (Wang et al 
2003). In addition, we demonstrated by infection with AD-MRTFA-
GFP that mechanical cues induce nuclear translocation of MRTFA 
independently of C26 CM presence.  
SRF is known to promote the increase of muscle mass by 
myoblasts recruitment, which fuse with myofibers (Guerci et al 
2012); SRF promotes cell growth too (Wallace et al 2016). The fact 
that SRF pathway is activated when the number and the size of 
myotubes increase, this suggests that SRF have the same effect in 
vitro. It looks like SRF could play an essential role in the 
preservation of muscle homeostasis in presence of mechanical 
stimulation. The fact that mechanical stimulation is sufficient per 
se to induce SRF expression and transcriptional activity, suggests 
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that this cue can be responsible for a direct effect of exercise on 
differentiated muscle cells and myoblasts. As a result, SRF can be 
considered as a key factor for muscle response to exercise in vivo. 
The data about upstream signals promoting MRTF-A /SRF 
transcriptional activity, suggest a model whereby the SRF pathway 
is activated by a modulation of actin network. In fact, the actin-
network responses to mechanical cues are characterised by F-actin 
polymerisation due to STARS and RhoA activation. As a 
consequence, MRTF-A is imported in nuclei to co-activate SRF 
target genes, which are involved in myogenic differentiation and 
myoblast recruitment to myotubes (Wallace et al., 2016). 
To explain the molecular mechanisms involved in myoblast 
recruitment and fusion with myotubes, we propose that SRF target 
genes (Cox2, integrin 1, IL-4) play a major role. In particular, 
integrins may stabilize cell-ECM interactions, further reinforcing 
adaptative responses to an elastic substrate, which is moving upon 
dynamic stretch, and reinforce at the same time intracellular 
signalling in response to mechanical cues. In addition, we observed 
a positive effect of cyclic stretch on IL-4 secretion by myotubes. In 
fact, SRF, via Cox2, is already known to induce IL-4 secretion by 
myotube to promote the fusion of myoblasts with myotubes 
(Guerci et al, 2012). The fact that we observe the same gene 
regulation in our model suggests that SRF induces IL-4 secretion via 
Cox2 in response to cyclic stretch. In turn, IL-4 recruits myoblasts 
and increases myotube diameter and dimensions counteracting 
the negative effects induced by the proinflammatory cytokines 
present in C26 CM.  
In conclusion, we propose the following model for the differential 
modulation of myotube homeostasis by atrophying factors of 
tumor origin and cyclic stretch.  C26 tumor cells induce Activin A 
increase and follistatin decrease affecting the milieu to which 
muscle cells are exposed, promoting pro-atrophy conditions. This 
likely activates Activin receptor-like kinase (Alk) via ActIIBR and 
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induces phosphorylates smad2-3 complex. Its nuclear translocation 
represses the transcription of myogenic genes, what could explain 
myotube atrophy that we observe in presence of CM. Mechanical 
cues can prevent the previously signalling by diminishing secretion 
of Activin A and increasing follistatin secretion. However, a 
supplementation with follistatin is not sufficient to restore the full 
hypertrophy capacity of myotubes, thus, this pathway could just 
contribute to limit the C26 dependent myotube atrophy. 
Mechano-transduction induced by cyclic stretch, counteracts 
atrophic effects of CM, by the activation of SRF via a modulation of 
actin network which responses to mechanical cues applied on cell. 
STARS, RhoA and the polymerisation of F-actin play a key role in 
nuclear translocation of MRTF-A and activation of SRF 
transcriptional activity. Indeed, SRF activation is necessary to 
mediate the beneficial effects of mechanical cues, as shown by the 
loss of function experiments. This general model has been 
summarized in Figure 20. Our study permits a better 
understanding of the mechanisms underlying cachexia.  
We have confirmed the importance of myoblast recruitment and 
fusion with myotubes to maintain muscle homeostasis. In addition, 
we have shown that purely mechanical cues play a major role, 
among the numerous responses to exercise in vivo, to counteract 
muscle atrophy in the presence of tumor derived factors.  Finally, 
our study suggests that the targeting of ActIIBR and the 
stimulation of SRF pathway by exercise or pharmacological 
treatments, turn out to be some relevant approaches to treat 
cachexia.  
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Figure 18: Graphical abstract of mechanical cue responses on SRF and ActIIBR 
pathways to counteract the negative effects of CM. 
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MATERIAL AND METHODS 
 
  8. Cell culture 
 
 8.1 C2C12 cell culture 
C2C12 are mouse myoblasts, cultivated in DMEM with 15% FBS, 
4.5g/L of glucose, 2mM of L-glutamine, 100ug/mL of penicillin-
streptomycin (Sigma, Saint Louis, MO), at 37°C, 5% of CO2. C2C12 
are seeded to obtain 80% of confluence and switched to 
differentiation medium with 2% horse serum, with or without 20% 
of C26 cell conditioned medium. 
 
8.2 C26 conditioned medium protocol 
C26 cell conditioned medium is obtained by cultivating the C26 cell 
line   for 2 days in DMEM and 1% of penicillin-streptomycin 
without serum. The supernatant is taken after the 2 days of culture 
and mixed to DM to obtain a final concentration of 2% horse 
serum and 20% of C26 cells conditioned medium. The control 
medium contains 2% of horse serum and 98% of DMEM which was 
incubated for 2 days at 37°C in the absence of C26 cells. 
 
 8.3 Flexcell 
Flexcell uses special multiwell plate with a silicone membrane 
which can be stretched when vacuum is applied under this 
membrane. In this way, C2C12 cells on this membrane are also 
stretched. C2C12 myoblasts are seed at 80% of confluence on the 
stretched area (3.89cm2) of each well. After 1 days of adhesion, 
growth medium is switched with differentiation medium for 4 
days. During this time the vacuum is constantly applied to stretch 
the membrane to 10%, in order to increase the membrane 
stiffness. This has been shown it was necessary to allow a proper 
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differentiation of the C2C12 cells in preliminary experiments (data 
not shown). After 4 days, in this condition we obtain a coculture of 
myotubes and myoblasts. From this moment   myogenic 
differentiation continues with 2% of horse serum in the presence 
or absence of 20% C26 cells conditioned medium and we apply or 
not mechanical cues by a release of vacuum under silicone 
membrane twice a day with the following stretching cycles:   2 
hours of treatment with stretch and relaxation cycles at a 
frequency of 0,5 Hz (10% of stretch). Between each dynamic 
stretch treatment 3 hours of pause are planned. In static stretch 
conditions the membrane is continuously stretch for the additional 
2 days of culture.  
 
 9. Infection by adenovirus MRTF-A-GFP 
 
C2C12 myoblasts are cultured for 3,5 days in antibiotic free 
differentiation medium, and then treated overnight with 
adenovirus MRTFA-GFP from Vartiainen MK, et al., 2007, with 
concentration of 100 MO. Following supernatant removal, cells are 
switched to the different treatment described above. 
 
  10. Cell treatment by recombinant follistatin 
 
C2C12 mixed cocultures of myoblasts and myotubes obtained as 
above are treated with 100ng/mL of recombinant follistatin 
(Fst288, Sigma) in presence of 2% horse serum and 20% C26 cells 
conditioned medium without mechanical cues. 
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11. SRF Knock-down   
 
C2C12 myoblasts are cultured for 3,5 days in antibiotic free 
differentiation medium  and then transfected with siRNA-SRF 
(Medjkane S et al., 2009) in presence of lipofectamine 2000 and 
RNAmax (Life technologies) overnight. Following supernatant 
removal, cells are swiched to the different treatment described 
above. 
 
12. Immunofluorescence 
 
For immunofluorescence analysis, we fix the samples with 
formaldehyde 3.7% in PBS for 10min and we rinse with PBS. We 
use a blocking/permeabilizing buffer containing 1% bovine serum 
albumin (BSA), 10% goat serum and 0,2 % Triton in PBS. We use 
antibodies anti-myosin heavy chain (Sigma), or F5D anti-myogenin. 
The secondary antibody is the anti-mouse Alexafluor 555 
(Molecular probes, Invitrogen), while Hoescht is used for nuclear 
staining. 
 
13. RNA extraction, c DNA synthesis and Q –PCR 
 
Total RNA is isolated from C2C12 samples, with Trizol® reagent 
(Invitrogen) following the manufacturer’s recommendations and 
homogenized. RNA concentration is determined by measuring the 
absorbance in 260nm/280nm in a NanoDrop spectrophotometer. 
Then, cDNA synthesis is carried out using the High capacity applied 
Reverse Transcription Kit (Biosystem). Lightcycler 480 is used to 
detected SYBR Green signal in Q-PCR. The mRNA levels are 
determined by the comparative Ct method. For each sample, a ΔCt 
value is obtained by subtracting GAPDH gene values from those of 
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the gene of interest. The average ΔCt value of the control group is 
subtracted from the sample to derive a −ΔΔCt value. The 
expression of each gene is evaluated by 2−ΔΔCt, according to Livak 
and Schmittgen (Livak KJ et al., 2001). 
 
List of primers used in this study: 
R: TGT-GGC-ATT-TTC-TGC-TCC-GTG-G 
F: TGA-CAT-GCC-CAA-GAC-TCA 
IGF-1Ea
R: GGT-GAT-GTG-GCA-TTT-CCT-GCT 
F: AGC-TGC-AAA-GGA-GAA-GGA-AAG-GAA-G 
IGF-1Ec/MGF
R: CTT-CTC-AGA-TGC-AAG-GCT-CA
F: TCC-GTC-GGT-TCT-CTC-CAT-AG
RhoA
R: CCA-CCT-TCT-GGA-GAA-TCC-AA
F: AAC-RGC-ACC-AGC-CCA-TTT-AG
IGF-1
R:GGA- GCG-CAA-GTT-TGT-CAT-AAG-T
F: CTC-AAG-CTG-CTC-AGC-AAT-CTA-TTT
Myh7
R: TAT-CCT-CCA-CCG-TGA-TGC-TG
F: GCA-CTG-GAG-TTC-GGT-CCC-AA 
Myogenin
R: GGG-AGT-TTG-CGT-TCC-TCT-GA
F: GAA-GGA-GGA-GCA-AAC-GTG-GA 
MRF4
R: TGG-CAT-GAT-GGA-TTA-CAG-CG
F: GAG-ATG-CGC-TCC-ACT-ATG-CT
MyoD
R: CAT-CCG-CTA-CAT-TGA-GAG-CCT-C
F: TAC-ATC-AGG-ACA-GTA-GAT-GCT-GTC
Myf5
R: TGT-GGC-GAG-CCA-TTG-TGC-GG
F:GAA-AGG-GCC-AAG-CGA-GCG-GA
STARS
R: GCT-GTG-TGG-ATT-GTG-GAG-GT
F: CAC-CTA-CCA-GGT-GTC-GGA-AT
SRF
R: ACC-TTT-GGC-TTC-AGC-TCC-TT
F: ACC-TCT-GCT-GCC-CCC-AAG-CC
MRTF-A
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R: ACA-CAT-TGG-GGG-TAG-GAA-CA
F: AAC-TTT-GGC-ATT-GTG-GAA-GG
GAPDH
R: GCA-GCT-GAA-CAC-CAC-ACA-CT
F: AGA-AGG-TGG-AGC-CTA-GCA-CA
Integrin 7
R: CCA-CCT-TCT-GGA-GAA-TCC-AA
F: AAC-TGC-ACC-AGC-CCA-TTT-AG
Integrin 1
R: AAG-AAA-TAG-GGG-GAG-CCT-GA
F: AGG-CCT-TCT-TCC-TGG-ATG-TT
Vinculin
R: GCT-CGG-CTT-CCA-GTA-TTG-AG 
F: GTG-GAA-AAA-CCT-CGT-CCA-GA 
Cox2
R: AGA-GCC-GTT-GTC-ACA-CAC-AA 
F: CGT-GAA-GCC-TCA-CTT-CCT-ACC 
Skeletal actin
 
 
14. ELISA 
 
In order to evaluate the concentration of factors secreted by the 
cell cultures in every condition, ELISA quantikine kits MG100 
Mouse/Rat IGF-1, DAC00B Human/Mouse Activin A, DGDF80 gdf-
8/myostatin, DFN00 from R&D systems are used. 
 
15. Western Blot 
 
 15.1 Western Blot  
Samples are treated with lysis buffer RIPA which contains Tris-Cl 50 
Mm pH=7.5, 150Mm NaCl, 1% NP40, 0.5% desoxyclorate de 
sodium, EGTA 20mM, DTT 1mM, and an protease inhibitor 
cocktail. Proteins are denatured with a Bolt kit (Molecular probes, 
Invitrogen). The running period is 20 min at 200V with the Blot kit, 
and the transfer period is 20 min at 100V. Membrane of 
nitrocellulose is incubated with blocking buffer TBS-Tween with 5% 
not fat milk. The primary antibodies anti-MyoD, F5D (anti-
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myogenin), MF20 (anti-myosin), anti-smad2-3 (Cell signalling), anti-
phospho-smad2-3 (Cell signalling), anti-integrin 7 (Cell signalling), 
anti-SRF (Santa Cruz), anti-RhoA (Cell signalling), anti-GAPDH 
(Sigma) are incubated with TBS-Tween 5% of BSA. The secondary 
antibodies are fluorescence antibodies anti-mouse and anti-rabbit 
which are detected by Odyssey system. Each lane containes 
protein extracts obtained by pooling three independent sample 
(cell culture wells).  
 
15.2 Western Blot of G and F actin 
The F on G actin ratio is evaluated accordingly to the method by 
Roan et al., 2014. Following F and G actin separation, the samples 
are running gels with 8% acrylamid, for 1hour at 200V. Transfer 
period on nitrocellulose membrane is 1hour at 100V. Membranes 
of nitrocellulose are incubated with blocking buffer TBS-Tween 
with 5% not fat milk. The primary antibody is an anti-sarcomeric 
actin (Sigma). The secondary antibody is a fluorescence anti-
mouse, combined with detection by the Odyssey system. 
  
  16. Imaging and quantification 
 
In the order to quantify different morphology parameters of 
myotubes, the acquisition of immunofluorescence images is done 
with Zeiss EM S3/SyCoP3 Macro-apotome with software Zen for 
macroscope in the imaging plateform from Institute of Biology 
PARIS-SEINE.  
Quantification of fusion index is defined by the number of nuclei in 
myotubes on total nuclei number in 5 fields per sample. We 
measure myotube diameter by the measure of myotube larger 
part. The counting of the nuclei number per myotube is done on 
fifty whole myotubes in the full sample image. All morphometric 
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analysis is done by Image J software. 
 
17. Statistical analysis 
 
The results were statistically analysed using TWO-WAY ANOVA to 
compare continuous variables between the 4 cell treatments 
examined. We also estimated multiple comparisons using the least 
significant difference test. The value of p < 0.05 was considered to 
indicate a statistically significant difference. Tukey HSD was used as 
a post-hoc test, whenever two ANOVA indicated interactions 
legitimating the use of this test. Simple comparisons were 
statistically analysed using ONE-WAY ANOVA. P values of < 0.05 
were considered statistically significant. 
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